Key result
Multidisciplinary CTEPH management combines multimodal imaging, hemodynamics, endarterectomy, angioplasty, and targeted medical therapy.
Answers are grounded in this paper and cite their sources.
Reviews diagnostic and therapeutic approaches for chronic thromboembolic pulmonary hypertension, highlighting the necessity of individualized care by multidisciplinary teams.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism. It is caused by persistent obstruction of pulmonary arteries by chronic organised fibrotic clots, despite adequate anticoagulation. The pulmonary hypertension is also caused by concomitant microvasculopathy which may progress without timely treatment. Timely and accurate diagnosis requires the combination of imaging and haemodynamic assessment. Optimal therapy should be individualised to each case and determined by an experienced multidisciplinary CTEPH team with the ability to offer all current treatment modalities. This report summarises current knowledge and presents key messages from the International CTEPH Conference, Bad Nauheim, Germany, 2021. Sessions were dedicated to 1) disease definition; 2) pathophysiology, including the impact of the hypertrophied bronchial circulation, right ventricle (dys)function, genetics and inflammation; 3) diagnosis, early after acute pulmonary embolism, using computed tomography and perfusion techniques, and supporting the selection of appropriate therapies; 4) surgical treatment, pulmonary endarterectomy for proximal and distal disease, and peri-operative management; 5) percutaneous approach or balloon pulmonary angioplasty, techniques and complications; and 6) medical treatment, including anticoagulation and pulmonary hypertension drugs, and in combination with interventional treatments. Chronic thromboembolic pulmonary disease without pulmonary hypertension is also discussed in terms of its diagnostic and therapeutic aspects.
No takes yet. Share an insight, caveat, or question.
Simonneau et al. (2023) conducted a review in Chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary disease. Pulmonary endarterectomy, balloon pulmonary angioplasty, and medical therapy was evaluated. Multidisciplinary CTEPH management combines imaging, hemodynamic assessment, pulmonary endarterectomy, balloon pulmonary angioplasty, and medical therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: